Connie P.M. Duong

Medicine · Health Sciences

24h-index12.8kcitations75works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(42), Virus-based gene therapy research(19), Cancer Immunotherapy and Biomarkers(16), Immunotherapy and Immune Responses(14), Cancer Research and Treatments(14)

Publications75 total

Supplementary Figure from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
2023Open Access
Data from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
2023Open Access
Supplementary Figure from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
2023Open Access
Supplementary Figure from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
2023Open Access
Data from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
2023Open Access
Supplementary Figure from Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
2023Open Access
Supplementary Figure 2 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Supplementary Figure Legends from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
upplementary Figure 3 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Data from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Data from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Supplementary Figure Legends from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Supplementary Figure 1 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
upplementary Figure 3 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Supplementary Figure 2 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Supplementary Figure 1 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2023Open Access
Supplementary Figure 3 from Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
2023Open Access
Supplementary Figure Legends 1-5 from Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
2023Open Access
Supplementary Figure 4 from Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
2023Open Access
Supplementary Figure 2 from Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Michael H. Kershaw(22), Phillip K. Darcy(22), Laurence Zitvogel(17), Mark J. Smyth(17), Liza B. John(16), Christel Devaud(16), Guido Kroemer(12), Carmen S. Yong(11), Gladys Ferrere(10), Jennifer A. Westwood(10), Lisa Derosa(9), Paule Opolon(9), Noriko Satake(9), Alexander Eggermont(8), Didier Raoult(8), Valerio Iebba(8), Romain Daillère(7), Nicolas Jacquelot(7), Jacqueline K. Flynn(7), Trina J. Stewart(7)